Accolade Inc
NASDAQ:ACCD
Accolade Inc
NASDAQ:ACCD
Price:
7.54 USD
3.86%
Market Closed
Updated:
May 4, 2024
Accolade Inc
Income from Continuing Operations
|
Accolade Inc
Income from Continuing Operations Peer Comparison
Comparables:
DVA
DGX
CVS
CI
LH
Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Income from Continuing Operations | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Accolade Inc
NASDAQ:ACCD
|
Income from Continuing Operations
-$459.7m
|
CAGR 3-Years
-108%
|
CAGR 5-Years
-50%
|
CAGR 10-Years
N/A
|
|
|
DaVita Inc
NYSE:DVA
|
Income from Continuing Operations
$957m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
4%
|
CAGR 10-Years
3%
|
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Income from Continuing Operations
$870m
|
CAGR 3-Years
-22%
|
CAGR 5-Years
4%
|
CAGR 10-Years
0%
|
|
|
CVS Health Corp
NYSE:CVS
|
Income from Continuing Operations
$7.4B
|
CAGR 3-Years
0%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
4%
|
|
|
Cigna Corp
NYSE:CI
|
Income from Continuing Operations
$5.4B
|
CAGR 3-Years
-14%
|
CAGR 5-Years
15%
|
CAGR 10-Years
14%
|
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Income from Continuing Operations
$400.3m
|
CAGR 3-Years
-47%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
-3%
|
See Also
What is Accolade Inc's Income from Continuing Operations?
Income from Continuing Operations
-459.7m
USD
-459.7m
USD
Based on the financial report for Feb 28, 2023, Accolade Inc's Income from Continuing Operations amounts to -459.7m USD.
What is Accolade Inc's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 5Y
-50%
-50%
Over the last year, the Income from Continuing Operations growth was -273%. The average annual Income from Continuing Operations growth rates for Accolade Inc have been -108% over the past three years , -50% over the past five years .
You don't have any saved screeners yet
